| SHH | Sonic Hedgehog |
| CSC | Cancer stem cells |
| GLI | Glioma-associated oncogene homolog |
| WNT | Wingless-activated |
| CAFs | Cancer-associated fibroblasts |
| SMO | Smoothened |
| GPCR | G protein-coupled receptor |
| SUFU | Suppressor of fused homolog |
| HH | Hedgehog |
| PKA | Protein kinase A |
| GTPase | Guanosine triphosphatase |
| PI3K | Phosphoinositide 3-kinase |
| mTOR | mammalian target of rapamycin |
| SBE7 | Shh brain enhancer 7 |
| VZ | Ventricular zone |
| TGF1β | Transforming growth factor 1 beta |
| YAP1 | Hippo/Yes-associated protein |
| HBx | HBV gene product HBx protein |
| CDK1 | cyclin-dependent kinase 1 |
| HCC | Hepatocellular carcinoma |
| EMT | epithelial-mesenchymal transition |
| FAK | focal adhesion kinase |
| TAMs | Tumor-associated macrophages |
| PDGF | Platelet-derived growth factor |
| MMP-2 | Matrix metalloproteinase-2 |
| HGF | hepatocyte growth factor |
| VEGFR | Vascular endothelial growth factor receptor |
| TGF-α | transforming growth factor-alpha |
| MDB5 | 2-chloro-N 1-[4-chloro-3-(2-pyridinyl)phenyl]-N 4,N 4-bis(2-pyridinylmethyl)-1,4-benzenedicarboxamide |
| HP | Helicobacter pylori |
| slfn4 | Schlafen 4 |
| BMPs | bone morphogenic proteins |
| BrdU | 5-Bromo-2′-Deoxyuridine |
| Bcl-2 | B-cell lymphoma 2 |
| c-Src | cellular Src kinase |
| ERα | Estrogen receptor alpha |
| ERK | Extracellular signal-regulated kinase |
| DICS | ductal carcinoma in situ |
| IBC | invasive breast cancer |
| CA | carbonic anhydrase |
| CYR61 | Cysteine-rich angiogenic induced 61 |
| ER | estrogen receptor |
| BC | breast cancer |
| TNBC | triple negative breast cancer |
| MDR-1 | multidrug resistant protein-1 |
| HIF-1α | Hypoxia-inducible factor 1-alpha |
| HERC4 | HECT and RLD domain containing E3 ubiquitin ligase 4 |